LaFleur & Godfrey LLC Cuts Stake in Procter & Gamble Co (NYSE:PG)

Share on StockTwits

LaFleur & Godfrey LLC reduced its stake in shares of Procter & Gamble Co (NYSE:PG) by 0.7% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 26,616 shares of the company’s stock after selling 193 shares during the period. LaFleur & Godfrey LLC’s holdings in Procter & Gamble were worth $2,918,000 as of its most recent SEC filing.

Several other hedge funds also recently made changes to their positions in the company. Essex Savings Bank acquired a new stake in Procter & Gamble during the fourth quarter valued at $2,158,000. TD Asset Management Inc. grew its position in shares of Procter & Gamble by 2.6% in the fourth quarter. TD Asset Management Inc. now owns 2,641,296 shares of the company’s stock valued at $242,788,000 after purchasing an additional 65,823 shares during the period. South Texas Money Management Ltd. grew its position in shares of Procter & Gamble by 2.6% in the fourth quarter. South Texas Money Management Ltd. now owns 18,015 shares of the company’s stock valued at $1,656,000 after purchasing an additional 449 shares during the period. State Treasurer State of Michigan grew its position in shares of Procter & Gamble by 6.8% in the fourth quarter. State Treasurer State of Michigan now owns 888,203 shares of the company’s stock valued at $81,644,000 after purchasing an additional 56,500 shares during the period. Finally, Sadoff Investment Management LLC grew its position in shares of Procter & Gamble by 2.1% in the fourth quarter. Sadoff Investment Management LLC now owns 403,746 shares of the company’s stock valued at $37,112,000 after purchasing an additional 8,361 shares during the period. Institutional investors and hedge funds own 65.63% of the company’s stock.

Procter & Gamble stock opened at $122.24 on Friday. The company’s 50 day simple moving average is $119.39 and its 200-day simple moving average is $110.29. The company has a market capitalization of $303.84 billion, a price-to-earnings ratio of 27.04, a price-to-earnings-growth ratio of 3.52 and a beta of 0.42. Procter & Gamble Co has a 1 year low of $78.49 and a 1 year high of $123.43. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.58 and a current ratio of 0.75.

Procter & Gamble (NYSE:PG) last released its quarterly earnings results on Tuesday, July 30th. The company reported $1.10 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.06 by $0.04. The business had revenue of $17.09 billion for the quarter, compared to the consensus estimate of $16.86 billion. Procter & Gamble had a net margin of 5.76% and a return on equity of 23.03%. The business’s revenue was up 3.6% on a year-over-year basis. During the same period in the previous year, the firm earned $0.94 EPS. Equities analysts expect that Procter & Gamble Co will post 4.84 earnings per share for the current year.

Several analysts have recently issued reports on the stock. Credit Suisse Group lifted their target price on shares of Procter & Gamble from $108.00 to $117.00 and gave the company a “neutral” rating in a research report on Wednesday, July 31st. Deutsche Bank lifted their target price on shares of Procter & Gamble from $106.00 to $109.00 and gave the company a “hold” rating in a research report on Monday, June 17th. Wells Fargo & Co reiterated a “buy” rating and issued a $135.00 target price (up previously from $125.00) on shares of Procter & Gamble in a research report on Tuesday, July 30th. Royal Bank of Canada reiterated a “neutral” rating and issued a $89.00 target price on shares of Procter & Gamble in a research report on Tuesday, July 30th. Finally, TheStreet lowered shares of Procter & Gamble from an “a-” rating to a “c+” rating in a research report on Tuesday, July 30th. One investment analyst has rated the stock with a sell rating, eleven have assigned a hold rating and eleven have assigned a buy rating to the company. Procter & Gamble currently has a consensus rating of “Hold” and a consensus target price of $108.89.

In related news, VP Valarie L. Sheppard sold 17,000 shares of Procter & Gamble stock in a transaction that occurred on Wednesday, July 31st. The shares were sold at an average price of $120.20, for a total value of $2,043,400.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, VP Valarie L. Sheppard sold 1,259 shares of Procter & Gamble stock in a transaction that occurred on Tuesday, August 27th. The shares were sold at an average price of $120.36, for a total transaction of $151,533.24. Following the completion of the transaction, the vice president now owns 26,094 shares of the company’s stock, valued at approximately $3,140,673.84. The disclosure for this sale can be found here. Insiders sold a total of 448,674 shares of company stock worth $53,197,461 over the last three months. Insiders own 1.75% of the company’s stock.

About Procter & Gamble

The Procter & Gamble Company provides branded consumer packaged goods to consumers in North America, Europe, the Asia Pacific, Greater China, Latin America, India, the Middle East, and Africa. The company operates in five segments: Beauty; Grooming; health Care; fabric & Home Care; and Baby, Feminine & Family Care.

Featured Story: Why do companies pay special dividends?

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Co (NYSE:PG).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

SOTHERLY HOTELS/SH SH  Upgraded by Zacks Investment Research to Hold
SOTHERLY HOTELS/SH SH Upgraded by Zacks Investment Research to Hold
Solaredge Technologies  Lowered to Hold at Zacks Investment Research
Solaredge Technologies Lowered to Hold at Zacks Investment Research
Resonant  Upgraded to “Hold” at Zacks Investment Research
Resonant Upgraded to “Hold” at Zacks Investment Research
Portola Pharmaceuticals  PT Lowered to $44.00
Portola Pharmaceuticals PT Lowered to $44.00
UltraNote Coin Reaches Market Cap of $13,486.00
UltraNote Coin Reaches Market Cap of $13,486.00
FS KKR Capital Corp  Receives $7.63 Consensus PT from Analysts
FS KKR Capital Corp Receives $7.63 Consensus PT from Analysts


© 2006-2019 Ticker Report